[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices]               
[Page 16713]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-114]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 17, 2007, and published in the Federal 
Register on December 27, 2007, (72 FR 73358), GE Healthcare, 3350 North 
Ridge Avenue, Arlington Heights, Illinois 60004-1412, made application 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Cocaine (9041), a basic class of controlled substance 
listed in schedule II.
    The company plans to manufacture a radioactive product used in 
diagnostic imaging in the diagnosis of Parkinson's Disease and for 
manufacture in bulk for investigational new drug (IND) submission and 
clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
GE Healthcare to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated GE Healthcare to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with State and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic class of controlled substance listed.

    Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-6389 Filed 3-27-08; 8:45 am]

BILLING CODE 4410-09-P